“…Further, lactate suppresses the induction of the NLRP3 inflammasome and IL1b via GPR81 activation, regulates TLR activation via interactions with arrestin B2 downstream of GPR81, and protects against inflammatory injury in pancreatitis and hepatitis models through GPR81 signaling (Hoque et al, 2014). Mtb infection has been demonstrated to inhibit NLRP3 inflammasome activation and (Hanahan and Weinberg, 2011;Vaupel et al, 2019) • Regulated by HIF-1a, which controls expression of LDHA (Ivan et al, 2001;Jaakkola et al, 2001;Kaluz et al, 2006) • LDHA is a poor prognostic indicator and correlated to increased tumor size (Koukourakis et al, 2003;Koukourakis et al, 2005;Kolev et al, 2008) • Lactate accumulates within the tumor microenvironment (Walenta and Mueller-Klieser, 2004) • Glycolysis enhanced early during in vitro Mtb infection (Shi et al, 2015;Qualls and Murray, 2015;Gleeson et al, 2016;Shi et al, 2019) • HIF-1a expressed and active during Mtb infection (Shi et al, 2015;Braverman et al, 2016;Prosser et al, 2017;Baay-Guzman et al, 2018;Knight and Stanley, 2019;Resende et al, 2020) • Deletion of HIF-1a impacts granuloma necrosis, host responses, and chronic inflammation (Elks et al, 2013;Cardoso et al, 2015;Ogryzko et al, 2019;Schild et al, 2020) • LDHA increased in Mtb infection within macrophages and T cells (Shi et al, 2015) • Increased serum and BAL LDH within TB patients (Emad and Rezaian, 1999;Sharma et al, 2010) • Increased lactate within TB granulomas (Somashekar et al, 2011;Somashekar et al, 2012) • Increased CSF lactate in tuberculous meningitis correlates with disease severity…”